Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26K Sell
18
-129
-88% -$9.87K ﹤0.01% 1603
2026
Q1
$12.5K Buy
147
+137
+1,370% +$13K ﹤0.01% 927
2025
Q4
$953 Hold
10
﹤0.01% 1113
2025
Q3
$1.3K Hold
10
﹤0.01% 1077
2025
Q2
$1.13K Hold
10
﹤0.01% 1077
2025
Q1
$927 Hold
10
﹤0.01% 1128
2024
Q4
$1.07K Hold
10
﹤0.01% 1080
2024
Q3
$1.03K Hold
10
﹤0.01% 1073
2024
Q2
$881 Hold
10
﹤0.01% 1093
2024
Q1
$981 Hold
10
﹤0.01% 1002
2023
Q4
$924 Buy
+10
New +$849 ﹤0.01% 992
2023
Q3
Sell
-10
Closed -$847 231
2023
Q2
$847 Hold
10
﹤0.01% 960
2023
Q1
$843 Hold
10
﹤0.01% 913
2022
Q4
$849 Hold
10
﹤0.01% 874
2022
Q3
$1K Sell
10
-20
-67% -$1.42K ﹤0.01% 828
2022
Q2
$2K Sell
30
-95
-76% -$6.64K ﹤0.01% 817
2022
Q1
$10K Buy
125
+115
+1,150% +$8.44K ﹤0.01% 670
2021
Q4
$1K Buy
+10
New +$702 ﹤0.01% 860
2021
Q3
Sell
-125
Closed -$8K 360
2021
Q2
$8K Buy
125
+115
+1,150% +$7.52K ﹤0.01% 690
2021
Q1
$1K Buy
+10
New +$569 ﹤0.01% 735

Other funds holding ACM

CVA Family Office's ACM Position: Q2 2026 in Review

CVA Family Office reduced its Aecom (ACM) stake by 88% in Q2 2026, selling an estimated $9.87K and leaving 18 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

CVA Family Office first reported a position in ACM in Q1 2021 and has held it in 20 quarters since. The position peaked at $12.5K in Q1 2026. 568 funds tracked by Wall St. Rank hold ACM as of Q2 2026.

  • CVA Family Office held 18 shares of Aecom worth $1.26K as of Q2 2026.
  • CVA Family Office sold 129 Aecom shares in Q2 2026, an estimated $9.87K.
  • Aecom made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1603 holding.
  • CVA Family Office first reported a position in Aecom in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Aecom position peaked at $12.5K in Q1 2026.
  • 568 funds tracked by Wall St. Rank held Aecom as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.